Mitochondrial redox system: A key target of antioxidant therapy to prevent acquired sensorineural hearing loss

Area of Science:

• Oto-pharmacology
• Neuroscience
• Cellular Biology

Background:

• Acquired sensorineural hearing loss stems from noise, ototoxic drugs, and aging.
• Oxidative stress, particularly mitochondrial reactive oxygen species (ROS) imbalance, is a key factor in hearing loss.
• Current research focuses on protecting cochlear hair cells and auditory nerves.

Purpose of the Study:

• To review the potential of targeting mitochondrial redox networks for hearing loss prevention and treatment.
• To explore therapeutic strategies against noise- and drug-induced ototoxicity.
• To highlight the role of antioxidants in maintaining hearing function.

Main Methods:

• Literature review of pathological mechanisms in acquired hearing loss.
• Analysis of the role of mitochondrial redox homeostasis in auditory cells.
• Investigation of antioxidant strategies against ototoxic stimuli.

Main Results:

• Mitochondrial ROS imbalance is implicated in acquired sensorineural hearing loss.
• Antioxidants show promise in supporting auditory cell function.
• Targeting specific elements of the mitochondrial redox network is a viable therapeutic avenue.

Conclusions:

• Developing drugs targeting the mitochondrial redox network offers a promising strategy for preventing and treating noise- and ototoxic drug-induced hearing loss.
• Further research into redox homeostasis in hair cells is crucial.
• Antioxidant therapies hold potential for preserving hearing function.